These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21550006)

  • 1. Evaluation of immune response to hepatitis A vaccination and vaccine safety in juvenile idiopathic arthritis.
    Erguven M; Kaya B; Hamzah OY; Tufan F
    J Chin Med Assoc; 2011 May; 74(5):205-8. PubMed ID: 21550006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and safety of the inactivated hepatitis A vaccine in children with juvenile idiopathic arthritis on methotrexate treatment: a matched case-control study.
    Maritsi DN; Coffin SE; Argyri I; Vartzelis G; Spyridis N; Tsolia MN
    Clin Exp Rheumatol; 2017; 35(4):711-715. PubMed ID: 28721859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The vaccine coverage and vaccine immunity status and risk factors of non-protective levels of antibodies against vaccines in children with juvenile idiopathic arthritis: cross-sectional Russian tertiary Centre study.
    Kostik MM; Lubimova NA; Fridman IV; Goleva OV; Kharit SM
    Pediatr Rheumatol Online J; 2021 Jul; 19(1):108. PubMed ID: 34225748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short and long-term immunogenicity and safety following the 23-valent polysaccharide pneumococcal vaccine in juvenile idiopathic arthritis patients under conventional DMARDs with or without anti-TNF therapy.
    Aikawa NE; França IL; Ribeiro AC; Sallum AM; Bonfa E; Silva CA
    Vaccine; 2015 Jan; 33(5):604-9. PubMed ID: 25554240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety and effectiveness of HBV vaccination in patients with juvenile idiopathic arthritis controlled by treatment.
    Nerome Y; Akaike H; Nonaka Y; Takezaki T; Kubota T; Yamato T; Yamasaki Y; Imanaka H; Kawano Y; Takei S
    Mod Rheumatol; 2016; 26(3):368-71. PubMed ID: 26471922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Markedly decreased antibody titers against hepatitis B in previously immunised children presenting with juvenile idiopathic arthritis.
    Maritsi D; Vartzelis G; Soldatou A; Garoufi A; Spyridis N
    Clin Exp Rheumatol; 2013; 31(6):969-73. PubMed ID: 23806191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of hepatitis A vaccination in kidney transplant recipients.
    Jeon HJ; Ro H; Jeong JC; Koo TY; Han M; Min SI; Oh KH; Ha J; Ahn C; Yang J
    Transpl Infect Dis; 2014 Jun; 16(3):511-5. PubMed ID: 24750343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of influenza vaccination in a prospective longitudinal study of 31 children with juvenile idiopathic arthritis.
    Toplak N; Subelj V; Kveder T; Cucnik S; Prosenc K; Trampus-Bakija A; Todorovski L; Avcin T
    Clin Exp Rheumatol; 2012; 30(3):436-44. PubMed ID: 22513085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B vaccination in children with juvenile idiopathic arthritis.
    Kasapçopur O; Cullu F; Kamburoğlu-Goksel A; Cam H; Akdenizli E; Calýkan S; Sever L; Arýsoy N
    Ann Rheum Dis; 2004 Sep; 63(9):1128-30. PubMed ID: 15308522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of response criteria to evaluate therapeutic response in patients with juvenile idiopathic arthritis treated with methotrexate and/or anti-tumor necrosis factor alpha agents.
    Lurati A; Pontikaki I; Teruzzi B; Desiati F; Gerloni V; Gattinara M; Cimaz R; Fantini F
    Arthritis Rheum; 2006 May; 54(5):1602-7. PubMed ID: 16646003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B vaccination response of treatment-naive patients with juvenile idiopathic arthritis.
    Çakmak F; Çakan M; Demir F; Sonmez HE; Çakmak S; Demirkan FG; Karadağ ŞG; Ayaz NA; Sözeri B
    Rheumatol Int; 2022 Jul; 42(7):1199-1205. PubMed ID: 33738550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and safety of a pediatric dose of a virosomal hepatitis A vaccine in healthy children in India.
    Jain H; Kumavat V; Singh T; Versteilen A; Sarnecki M
    Hum Vaccin Immunother; 2014; 10(7):2089-97. PubMed ID: 25424821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interchangeability of a hepatitis A vaccine second dose: Avaxim 80 following a first dose of Vaqta 25 or Havrix 720 in children in Turkey.
    Soysal A; Gokçe I; Pehlivan T; Bakir M
    Eur J Pediatr; 2007 Jun; 166(6):533-9. PubMed ID: 17318620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and safety of influenza vaccination in patients with juvenile idiopathic arthritis on biological therapy using the microneutralization assay.
    Camacho-Lovillo MS; Bulnes-Ramos A; Goycochea-Valdivia W; Fernández-Silveira L; Núñez-Cuadros E; Neth O; Pérez-Romero P
    Pediatr Rheumatol Online J; 2017 Aug; 15(1):62. PubMed ID: 28784185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the safety and immunogenicity of live attenuated and inactivated hepatitis A vaccine in healthy Chinese children aged 18 months to 16 years: results from a randomized, parallel controlled, phase IV study.
    Ma F; Yang J; Kang G; Sun Q; Lu P; Zhao Y; Wang Z; Luo J; Wang Z
    Clin Microbiol Infect; 2016 Sep; 22(9):811.e9-811.e15. PubMed ID: 27345175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of the long-term antibody response after meningococcal C vaccination in patients with juvenile idiopathic arthritis: a retrospective cohort study.
    Stoof SP; Heijstek MW; Sijssens KM; van der Klis F; Sanders EA; Teunis PF; Wulffraat NM; Berbers GA
    Ann Rheum Dis; 2014 Apr; 73(4):728-34. PubMed ID: 23505231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Safety and immunogenicity of Bilive combined hepatitis A and B vaccine].
    Zhao YL; Chen YG; Li J; Han GX; Tian C; Liang JL; Li G; Wang ZG; Zhu YG; Tian ZN; Zhang HY; Wan ZJ; Liang ZL; Bi SL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):470-3. PubMed ID: 15231119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults.
    Van Damme P; Leroux-Roels G; Law B; Diaz-Mitoma F; Desombere I; Collard F; Tornieporth N; Van Herck K
    J Med Virol; 2001 Sep; 65(1):6-13. PubMed ID: 11505437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of immunogenicity between inactivated and live attenuated hepatitis A vaccines: a single-blind, randomized, parallel-group clinical trial among children in Xinjiang Uighur Autonomous Region, China.
    Liu XE; Wushouer F; Gou A; Kuerban M; Li X; Sun Y; Zhang J; Liu Y; Li J; Zhuang H
    Hum Vaccin Immunother; 2013 Jul; 9(7):1460-5. PubMed ID: 23571173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of quadrivalent HPV and combined hepatitis A and B vaccine when co-administered or administered one month apart to 9-10 year-old girls according to 0-6 month schedule.
    Gilca V; Sauvageau C; Boulianne N; De Serres G; Couillard M; Krajden M; Ouakki M; Murphy D; Trevisan A; Dionne M
    Hum Vaccin Immunother; 2014; 10(8):2438-45. PubMed ID: 25424952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.